EBIT adj. for impairment NOK 59m, vs ARCe/Cons at NOK 51m, driven by slight GM beatNOK 25m impairment on Lier warehouse as the process is taking longer than expectedGross margin 62.3% vs ARCe/Cons 61.4%. Small beat in both KID Interiør and HemtexOpex+D&A NOK 475m, spot on ARCe/ConsNo commentary on Q3
